CD274 and neoplasm: Mechanistically, glycosylation can stabilize PD-L1 at the tumor surface and alter matrix/receptor interactions that impede T-cell trafficking; ubiquitination controls checkpoint turnover and antigen-processing nodes; and phosphorylation integrates oncogenic signaling with interferon/NF-κB programs that polarize myeloid cells.